Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Obstructive Lung Diseases

  Free Subscription


01.01.2020

7 Am J Respir Cell Mol Biol
5 Am J Respir Crit Care Med
12 Ann Allergy Asthma Immunol
2 Ann Thorac Surg
1 Arch Bronconeumol
1 Arch Dis Child
1 BMJ
2 Can Respir J
1 Chest
2 Clin Exp Allergy
5 J Allergy Clin Immunol
11 J Asthma
1 Lancet
11 N Engl J Med
3 Pediatr Pulmonol
4 Pediatrics
1 PLoS Genet
14 PLoS One
15 Respir Res
3 Rev Mal Respir


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Cell Mol Biol

  1. SAKORNSAKOLPAT P, McCormack M, Bakke P, Gulsvik A, et al
    Genome-Wide Association Analysis of Single-Breath DlCO.
    Am J Respir Cell Mol Biol. 2019;60:523-531.
    PubMed     Text format     Abstract available

  2. DUNNE AE, Kawamatawong T, Fenwick PS, Davies CM, et al
    Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease.
    Am J Respir Cell Mol Biol. 2019;60:445-453.
    PubMed     Text format     Abstract available

  3. KIM D, Cho S, Castano MA, Panettieri RA, et al
    Biased TAS2R Bronchodilators Inhibit Airway Smooth Muscle Growth by Downregulating Phosphorylated Extracellular Signal-regulated Kinase 1/2.
    Am J Respir Cell Mol Biol. 2019;60:532-540.
    PubMed     Text format     Abstract available

  4. MATUSOVSKY OS, Kachmar L, Ijpma G, Panariti A, et al
    Contractile Properties of Intrapulmonary Airway Smooth Muscle in Cystic Fibrosis.
    Am J Respir Cell Mol Biol. 2019;60:434-444.
    PubMed     Text format     Abstract available

  5. GIORDANO L, Farnham A, Dhandapani PK, Salminen L, et al
    Alternative Oxidase Attenuates Cigarette Smoke-induced Lung Dysfunction and Tissue Damage.
    Am J Respir Cell Mol Biol. 2019;60:515-522.
    PubMed     Text format     Abstract available

  6. KHANNA K, Chaudhuri R, Aich J, Pattnaik B, et al
    Secretory Inositol Polyphosphate 4-Phosphatase Protects against Airway Inflammation and Remodeling.
    Am J Respir Cell Mol Biol. 2019;60:399-412.
    PubMed     Text format     Abstract available

  7. CHELVANAMBI S, Bogatcheva NV, Bednorz M, Agarwal S, et al
    HIV-Nef Protein Persists in the Lungs of Aviremic Patients with HIV and Induces Endothelial Cell Death.
    Am J Respir Cell Mol Biol. 2019;60:357-366.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  8. CHANDRASEKHAR R
    Socioeconomic Disparities and Health Outcomes.
    Am J Respir Crit Care Med. 2019;199:807-808.
    PubMed     Text format    

  9. RAJU S, Keet CA, Paulin LM, Matsui EC, et al
    Reply to Chandrasekhar: Socioeconomic Disparities and Health Outcomes.
    Am J Respir Crit Care Med. 2019;199:808-809.
    PubMed     Text format    

  10. BISWAS SK
    Acute and Chronic Effects of Cigarette Smoking on sRAGE.
    Am J Respir Crit Care Med. 2019;199:805.
    PubMed     Text format    

  11. POUWELS SD, Klont F, Kwiatkowski M, Wiersma VR, et al
    Reply to Biswas: Acute and Chronic Effects of Cigarette Smoking on sRAGE.
    Am J Respir Crit Care Med. 2019;199:806-807.
    PubMed     Text format    

  12. CHALMERS JD, Sibila O
    Happy Birthday Bronchiectasis: 200 Years of Targeting Mucus.
    Am J Respir Crit Care Med. 2019 Dec 20. doi: 10.1164/rccm.201911-2261.
    PubMed     Text format    


    Ann Allergy Asthma Immunol

  13. BLAISS MS, Steven GC, Bender B, Bukstein DA, et al
    Shared Decision Making for the Allergist.
    Ann Allergy Asthma Immunol. 2018 Aug 31. pii: S1081-1206(18)30710.
    PubMed     Text format    

  14. RICKARD K, MacDonald-Berko M, Anolik R, Jain N, et al
    Measurement of exhaled nitric oxide in young children.
    Ann Allergy Asthma Immunol. 2019;122:343-345.
    PubMed     Text format    

  15. REED BC, Waller JL, Ownby DR, Tingen MS, et al
    Association of exhaled nitric oxide with ethnicity and sex in rural Georgia youth.
    Ann Allergy Asthma Immunol. 2019;122:333-334.
    PubMed     Text format    

  16. ANDERSON WC 3RD, Szefler SJ
    Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic?
    Ann Allergy Asthma Immunol. 2019;122:367-372.
    PubMed     Text format     Abstract available

  17. KALLIOLA S, Malmberg LP, Malmstrom K, Pelkonen AS, et al
    Airway hyperresponsiveness in young children with respiratory symptoms: A five-year follow-up.
    Ann Allergy Asthma Immunol. 2019;122:492-497.
    PubMed     Text format     Abstract available

  18. GRAYSON MH, Oppenheimer J, Castells M, Nowak-Wegrzyn A, et al
    Life-long learning and the American Board of Allergy and Immunology: Practice improvement comes of age.
    Ann Allergy Asthma Immunol. 2019;123:6-8.
    PubMed     Text format    

  19. MARSHALL GD JR
    Practicing allergy-immunology in the 21(st) century:: Socioeconomic challenges.
    Ann Allergy Asthma Immunol. 2019;122:353-354.
    PubMed     Text format    

  20. BAPTIST AP, Hao W, Song PX, Carpenter L, et al
    A behavioral intervention can decrease asthma exacerbations in older adults.
    Ann Allergy Asthma Immunol. 2019 Dec 23. pii: S1081-1206(19)31493.
    PubMed     Text format     Abstract available

  21. VAN GANSE E, Texier N, Dima AL, Belhassen M, et al
    Effects of short- and long-acting beta-agonists on asthma exacerbations: a prospective cohort.
    Ann Allergy Asthma Immunol. 2019 Dec 17. pii: S1081-1206(19)31490.
    PubMed     Text format     Abstract available

  22. CASTELLS M
    Race and allergy: Are we that different?
    Ann Allergy Asthma Immunol. 2019;122:439-440.
    PubMed     Text format    

  23. VOLERMAN A, Toups MM, Hull A, Press VG, et al
    Does inhaler technique align with confidence among African-American children and their parents?
    Ann Allergy Asthma Immunol. 2019;123:100-101.
    PubMed     Text format    

  24. GERSTLAUER M, Szepfalusi Z, Golden D, Geng B, et al
    Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis.
    Ann Allergy Asthma Immunol. 2019 Apr 19. pii: S1081-1206(19)30295.
    PubMed     Text format    


    Ann Thorac Surg

  25. KURIHARA C, Fernandez R, Safaeinili N, Akbarpour M, et al
    Long-term impact of cytomegalovirus serologic status on lung transplantation in the United States.
    Ann Thorac Surg. 2018 Nov 23. pii: S0003-4975(18)31686.
    PubMed     Text format     Abstract available

  26. HORWOOD CR, Mansour D, Abdel-Rasoul M, Metzger G, et al
    Long-Term Results After Lung Volume Reduction Surgery: A Single Institution's Experience.
    Ann Thorac Surg. 2019;107:1068-1073.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  27. ARISMENDI E, Picado Valles C
    Current Role of Biomarkers in Severe Uncontrolled Asthma.
    Arch Bronconeumol. 2019 Dec 24. pii: S0300-2896(19)30331.
    PubMed     Text format    


    Arch Dis Child

  28. CARROLL W, Clayton S, Frost S, Gupta A, et al
    If it's 'only' asthma, why are children still dying?
    Arch Dis Child. 2019 Dec 23. pii: archdischild-2019-318215.
    PubMed     Text format    


    BMJ

  29. KEELEY D
    Inhaled corticosteroids for asthma: guidance is inconsistent.
    BMJ. 2019;367:l6934.
    PubMed     Text format    


    Can Respir J

  30. KALINAUSKAITE-ZUKAUSKE V, Januskevicius A, Janulaityte I, Miliauskas S, et al
    Serum Levels of Epithelial-Derived Cytokines as Interleukin-25 and Thymic Stromal Lymphopoietin after a Single Dose of Mepolizumab in Patients with Severe Non-Allergic Eosinophilic Asthma: A Short Report.
    Can Respir J. 2019;2019:8607657.
    PubMed     Text format     Abstract available

  31. FAVERIO P, Stainer A, De Giacomi F, Messinesi G, et al
    Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study".
    Can Respir J. 2019;2019:4897045.
    PubMed     Text format    


    Chest

  32. FAWZY A, Putcha N, Aaron CP, Bowler RP, et al
    Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.
    Chest. 2019;155:519-527.
    PubMed     Text format     Abstract available


    Clin Exp Allergy

  33. DELIU M, Fontanella S, Haider S, Sperrin M, et al
    Longitudinal trajectories of severe wheeze exacerbations from infancy to school age and their association with early-life risk factors and late asthma outcomes.
    Clin Exp Allergy. 2019 Dec 25. doi: 10.1111/cea.13553.
    PubMed     Text format     Abstract available

  34. SIO YY, Matta SA, Ng YT, Chew FT, et al
    Epistasis between Phenylethanolamine N-methyltransferase (PNMT) and beta2-adrenergic receptor (ADRB2) Influences Extracellular Epinephrine Level and Associates with the Susceptibility to Allergic Asthma.
    Clin Exp Allergy. 2019 Dec 19. doi: 10.1111/cea.13552.
    PubMed     Text format     Abstract available


    J Allergy Clin Immunol

  35. TURNER PJ, Fleming L, Saglani S, Southern J, et al
    Safety of Live Attenuated Influenza Vaccine in Children with Moderate-Severe Asthma.
    J Allergy Clin Immunol. 2019 Dec 18. pii: S0091-6749(19)31712.
    PubMed     Text format     Abstract available

  36. MENZIES-GOW A, Bafadhel M, Busse WW, Casale TB, et al
    An Expert Consensus Framework for Asthma Remission as a Treatment Goal.
    J Allergy Clin Immunol. 2019 Dec 19. pii: S0091-6749(19)31708.
    PubMed     Text format     Abstract available

  37. AKENROYE A, McCormack M, Keet C
    Severe Asthma in the US Population and Eligibility for Monoclonal Antibody Therapy.
    J Allergy Clin Immunol. 2019 Dec 19. pii: S0091-6749(19)31711.
    PubMed     Text format     Abstract available

  38. MESSINGER AI, Luo G, Deterding RR
    The Doctor will See You Now: How Machine Learning and Artificial Intelligence Can Extend Our Understanding and Treatment of Asthma.
    J Allergy Clin Immunol. 2019 Dec 25. pii: S0091-6749(19)32605.
    PubMed     Text format    

  39. JUHN Y, Liu H
    Natural language processing to advance EHR-based clinical research in Allergy, Asthma, and Immunology.
    J Allergy Clin Immunol. 2019 Dec 26. pii: S0091-6749(19)32604.
    PubMed     Text format     Abstract available


    J Asthma

  40. LANGLEY RJ, Dryden C, Westwood J, Anderson E, et al
    Once daily combined inhaled steroid and ultra long-acting bronchodilator prescribing in pediatric asthma: a dual Center retrospective cohort study.
    J Asthma. 2019 Dec 17:1-2. doi: 10.1080/02770903.2019.1702674.
    PubMed     Text format     Abstract available

  41. RUTLEN C, Orloff M, Bates J, Porter A, et al
    Crop Burning and the Prevalence of Asthma and COPD Emergency Department Treatments in a Rural Arkansas County.
    J Asthma. 2019 Dec 20:1-10. doi: 10.1080/02770903.2019.1708096.
    PubMed     Text format     Abstract available

  42. BOURDIN A, Shaw D, Menzies-Gow A, FitzGerald JM, et al
    Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma.
    J Asthma. 2019 Dec 26:1-9. doi: 10.1080/02770903.2019.1705333.
    PubMed     Text format     Abstract available

  43. FAROUQUE AS, Walker R, Erbas B
    Thunderstorm Asthma Epidemic - Management challenges experienced by general practice clinics.
    J Asthma. 2019 Dec 20:1-10. doi: 10.1080/02770903.2019.1708097.
    PubMed     Text format     Abstract available

  44. PRZYBYSZOWSKI M, Stachura T, Szafraniec K, Sladek K, et al
    The influence of self-assessment of asthma control on the Asthma Control Test outcome.
    J Asthma. 2019 Dec 30:1-10. doi: 10.1080/02770903.2019.1708098.
    PubMed     Text format     Abstract available

  45. SHADE L, Ludden T, Dolor RJ, Halladay J, et al
    Using the Consolidated Framework for Implementation Research (CFIR) to evaluate implementation effectiveness of a facilitated approach to an asthma shared decision making intervention.
    J Asthma. 2019 Dec 23:1-10. doi: 10.1080/02770903.2019.1702200.
    PubMed     Text format     Abstract available

  46. MULLEROVA H, Cockle SM, Gunsoy NB, Nelsen LM, et al
    Clinical Characteristics and Burden of Illness among Adolescent and Adult Patients with Severe Asthma by Asthma Control: the IDEAL Study.
    J Asthma. 2019 Dec 24:1-16. doi: 10.1080/02770903.2019.1708095.
    PubMed     Text format     Abstract available

  47. KUPCZYK M, Hofman A, Koltowski L, Kuna P, et al
    Home self-monitoring in patients with asthma using a mobile spirometry system.
    J Asthma. 2019 Dec 26:1-12. doi: 10.1080/02770903.2019.1709864.
    PubMed     Text format     Abstract available

  48. XIE L, Atem F, Gelfand A, Bauer C, et al
    United States Prevalence of Pediatric Asthma by Environmental Tobacco Smoke Exposure, 2016-2017.
    J Asthma. 2019 Dec 26:1-12. doi: 10.1080/02770903.2019.1709868.
    PubMed     Text format     Abstract available

  49. NAVANANDAN N, Moran E, Smith H, Hoch H, et al
    Primary Care Provider Preferences for Steroid Management of Acute Asthma Exacerbations in Children.
    J Asthma. 2019 Dec 26:1-10. doi: 10.1080/02770903.2019.1709869.
    PubMed     Text format     Abstract available

  50. SUN W, Pan L, Zhang W
    Risk factors for readmission of children hospitalized with acute asthma attacks in South China.
    J Asthma. 2019 Dec 29:1-10. doi: 10.1080/02770903.2019.1705334.
    PubMed     Text format     Abstract available


    Lancet

  51. BACHERT C, Han JK, Desrosiers M, Hellings PW, et al
    Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Lancet. 2019;394:1638-1650.
    PubMed     Text format     Abstract available


    N Engl J Med

  52. MACNEE W
    Beta-Blockers in COPD - A Controversy Resolved?
    N Engl J Med. 2019;381:2367-2368.
    PubMed     Text format    

  53. GLINZ D
    C-Reactive Protein for Antibiotic Use in COPD Exacerbations.
    N Engl J Med. 2019;381:2371.
    PubMed     Text format    

  54. VERBAKEL JY, Van den Bruel A, Thompson M
    C-Reactive Protein for Antibiotic Use in COPD Exacerbations.
    N Engl J Med. 2019;381:2371.
    PubMed     Text format    

  55. YILDIZ H
    C-Reactive Protein for Antibiotic Use in COPD Exacerbations.
    N Engl J Med. 2019;381:2371-2372.
    PubMed     Text format    

  56. BUTLER CC, Gillespie D, Francis NA
    C-Reactive Protein for Antibiotic Use in COPD Exacerbations. Reply.
    N Engl J Med. 2019;381:2372.
    PubMed     Text format    

  57. EAPEN MS, Sohal SS
    Update on the Pathogenesis of COPD.
    N Engl J Med. 2019;381:2483-2484.
    PubMed     Text format    

  58. AGUSTI A, Hogg JC
    Update on the Pathogenesis of COPD. Reply.
    N Engl J Med. 2019;381:2484.
    PubMed     Text format    

  59. CONTRERAS-GARZA BM
    Update on Clinical Aspects of COPD.
    N Engl J Med. 2019;381:2484-2485.
    PubMed     Text format    

  60. XIONG W, Guo X
    Update on Clinical Aspects of COPD.
    N Engl J Med. 2019;381:2485.
    PubMed     Text format    

  61. OROZCO-HERNANDEZ JP, Pacheco-Gallego M, Montoya-Martinez JJ
    Update on Clinical Aspects of COPD.
    N Engl J Med. 2019;381:2485.
    PubMed     Text format    

  62. CELLI BR, Wedzicha JA
    Update on Clinical Aspects of COPD. Reply.
    N Engl J Med. 2019;381:2485-2486.
    PubMed     Text format    


    Pediatr Pulmonol

  63. TRIVEDI M, Patel J, Hoque S, Mizrahi R, et al
    Alignment of stakeholder agendas to facilitate the adoption of school-supervised asthma therapy.
    Pediatr Pulmonol. 2019 Dec 19. doi: 10.1002/ppul.24611.
    PubMed     Text format     Abstract available

  64. MEDAR SS, Derespina KR, Jakobleff WA, Ushay MH, et al
    A winter to remember! Extracorporeal membrane oxygenation for life-threatening asthma in children: A case series and review of literature.
    Pediatr Pulmonol. 2019 Dec 20. doi: 10.1002/ppul.24616.
    PubMed     Text format     Abstract available

  65. LOVINSKY-DESIR S
    The use of biologic therapies for the management of pediatric asthma.
    Pediatr Pulmonol. 2019 Dec 27. doi: 10.1002/ppul.24613.
    PubMed     Text format     Abstract available


    Pediatrics

  66. CASTRO-RODRIGUEZ JA, Abarca K, Forno E
    Asthma and the Risk of Invasive Pneumococcal Disease: A Meta-analysis.
    Pediatrics. 2019 Dec 16. pii: peds.2019-1200. doi: 10.1542/peds.2019-1200.
    PubMed     Text format     Abstract available

  67. TAN TQ
    Asthma and Invasive Pneumococcal Disease in the Age of Pneumococcal Conjugate Vaccines.
    Pediatrics. 2019 Dec 16. pii: peds.2019-3360. doi: 10.1542/peds.2019-3360.
    PubMed     Text format    

  68. SEASE KK, Amati JB
    "Housing First" for Optimal Child Health.
    Pediatrics. 2019;144.
    PubMed     Text format    

  69. PAPPALARDO AA, Gerald LB
    Let Them Breathe: A Plea to Pediatricians to Advocate for Stock Inhaler Policies at School.
    Pediatrics. 2019;144.
    PubMed     Text format    


    PLoS Genet

  70. SAFERALI A, Yun JH, Parker MM, Sakornsakolpat P, et al
    Analysis of genetically driven alternative splicing identifies FBXO38 as a novel COPD susceptibility gene.
    PLoS Genet. 2019;15:e1008229.
    PubMed     Text format     Abstract available


    PLoS One

  71. PRAMONO RXA, Imtiaz SA, Rodriguez-Villegas E
    Evaluation of features for classification of wheezes and normal respiratory sounds.
    PLoS One. 2019;14:e0213659.
    PubMed     Text format     Abstract available

  72. ANAZAWA R, Kawata N, Matsuura Y, Ikari J, et al
    Longitudinal changes in structural lung abnormalities using MDCT in chronic obstructive pulmonary disease with asthma-like features.
    PLoS One. 2019;14:e0227141.
    PubMed     Text format     Abstract available

  73. BREW BK, Chiesa F, Lundholm C, Ortqvist A, et al
    A modern approach to identifying and characterizing child asthma and wheeze phenotypes based on clinical data.
    PLoS One. 2019;14:e0227091.
    PubMed     Text format     Abstract available

  74. SAHEB SHARIF-ASKARI N, Sharif HA, Saheb Sharif-Askari F, Hamid Q, et al
    Association between body mass index and asthma severity in Arab pediatric population: A retrospective study.
    PLoS One. 2019;14:e0226957.
    PubMed     Text format     Abstract available

  75. WEI C, Tang X, Wang F, Li Y, et al
    Molecular characterization of pulmonary defenses against bacterial invasion in allergic asthma: The role of Foxa2 in regulation of beta-defensin 1.
    PLoS One. 2019;14:e0226517.
    PubMed     Text format     Abstract available

  76. ROBERTSON TE, Nouraie M, Qin S, Crothers KA, et al
    HIV infection is an independent risk factor for decreased 6-minute walk test distance.
    PLoS One. 2019;14:e0212975.
    PubMed     Text format     Abstract available

  77. KASSEM E, Na'amnih W, Bdair-Amsha A, Zahalkah H, et al
    Comparisons between ethnic groups in hospitalizations for respiratory syncytial virus bronchiolitis in Israel.
    PLoS One. 2019;14:e0214197.
    PubMed     Text format     Abstract available

  78. MCGILL JL, Guerra-Maupome M, Schneider S
    Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease.
    PLoS One. 2019;14:e0214407.
    PubMed     Text format     Abstract available

  79. AUSTIN V, Miller A, Vlahos R
    Prior cigarette smoke exposure does not affect acute post-stroke outcomes in mice.
    PLoS One. 2019;14:e0214246.
    PubMed     Text format     Abstract available

  80. SANDBERG J, Engstrom G, Ekstrom M
    Breathlessness and incidence of COPD, cardiac events and all-cause mortality: A 44-year follow-up from middle age throughout life.
    PLoS One. 2019;14:e0214083.
    PubMed     Text format     Abstract available

  81. ELSHAFEE AS, Karch A, Ringe KI, Shin HO, et al
    Complications of CT-guided lung biopsy with a non-coaxial semi-automated 18 gauge biopsy system: Frequency, severity and risk factors.
    PLoS One. 2019;14:e0213990.
    PubMed     Text format     Abstract available

  82. ENGLE ML, Monk JN, Jania CM, Martin JR, et al
    Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice.
    PLoS One. 2019;14:e0212866.
    PubMed     Text format     Abstract available

  83. LEWTHWAITE H, Olds T, Williams MT, Effing TW, et al
    Use of time in chronic obstructive pulmonary disease: Longitudinal associations with symptoms and quality of life using a compositional analysis approach.
    PLoS One. 2019;14:e0214058.
    PubMed     Text format     Abstract available

  84. BURKES RM, Astemborski J, Lambert AA, Brown TT, et al
    Plasma cathelicidin and longitudinal lung function in current and former smokers.
    PLoS One. 2019;14:e0212628.
    PubMed     Text format     Abstract available


    Respir Res

  85. LI N, He Y, Yang G, Yu Q, et al
    Role of TRPC1 channels in pressure-mediated activation of airway remodeling.
    Respir Res. 2019;20:91.
    PubMed     Text format     Abstract available

  86. IBRAHIM H, O'Sullivan R, Casey D, Murphy J, et al
    The effectiveness of Reslizumab in severe asthma treatment: a real-world experience.
    Respir Res. 2019;20:289.
    PubMed     Text format     Abstract available

  87. KARMAUS W, Mukherjee N, Janjanam VD, Chen S, et al
    Distinctive lung function trajectories from age 10 to 26 years in men and women and associated early life risk factors - a birth cohort study.
    Respir Res. 2019;20:98.
    PubMed     Text format     Abstract available

  88. LEAKER BR, Singh D, Lindgren S, Almqvist G, et al
    Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.
    Respir Res. 2019;20:288.
    PubMed     Text format     Abstract available

  89. CHEN YF, Huang G, Wang YM, Cheng M, et al
    Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice.
    Respir Res. 2019;20:285.
    PubMed     Text format     Abstract available

  90. GERN JE, Jackson DJ, Lemanske RF Jr, Seroogy CM, et al
    The Children's Respiratory and Environmental Workgroup (CREW) birth cohort consortium: design, methods, and study population.
    Respir Res. 2019;20:115.
    PubMed     Text format     Abstract available

  91. PRAGMAN AA, Knutson KA, Gould TJ, Isaacson RE, et al
    Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Respir Res. 2019;20:114.
    PubMed     Text format     Abstract available

  92. ROGLIANI P, Matera MG, Page C, Puxeddu E, et al
    Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
    Respir Res. 2019;20:104.
    PubMed     Text format     Abstract available

  93. MIHALTAN F, Adir Y, Antczak A, Porpodis K, et al
    Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study.
    Respir Res. 2019;20:89.
    PubMed     Text format     Abstract available

  94. FAWZY A, Anderson JA, Cowans NJ, Crim C, et al
    Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
    Respir Res. 2019;20:86.
    PubMed     Text format     Abstract available

  95. REN Y, Zhang Y, Fan L, Jiao Q, et al
    The cullin4A is up-regulated in chronic obstructive pulmonary disease patient and contributes to epithelial-mesenchymal transition in small airway epithelium.
    Respir Res. 2019;20:84.
    PubMed     Text format     Abstract available

  96. TANABE N, Sato S, Oguma T, Shima H, et al
    Associations of airway tree to lung volume ratio on computed tomography with lung function and symptoms in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:77.
    PubMed     Text format     Abstract available

  97. RODRIGUES FM, Demeyer H, Loeckx M, Hornikx M, et al
    Health status deterioration in subjects with mild to moderate airflow obstruction, a six years observational study.
    Respir Res. 2019;20:93.
    PubMed     Text format     Abstract available

  98. MCDONALD MN, Wouters EFM, Rutten E, Casaburi R, et al
    It's more than low BMI: prevalence of cachexia and associated mortality in COPD.
    Respir Res. 2019;20:100.
    PubMed     Text format     Abstract available

  99. WANG Z, Maschera B, Lea S, Kolsum U, et al
    Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:113.
    PubMed     Text format     Abstract available


    Rev Mal Respir

  100. UNDERNER M, Perriot J, Peiffer G, Jaafari N, et al
    [Electronic cigarette use and asthma in adolescents].
    Rev Mal Respir. 2019 Dec 18. pii: S0761-8425(19)31046.
    PubMed     Text format    

  101. GUGUEN C, Launois C, Dormoy V, Dewolf M, et al
    [Obesity and asthma: Mechanisms and therapeutic options].
    Rev Mal Respir. 2019 Dec 18. pii: S0761-8425(19)31039.
    PubMed     Text format     Abstract available

  102. VILLENEUVE T, Guilleminault L
    [Asthma and obesity in adults].
    Rev Mal Respir. 2019 Dec 19. pii: S0761-8425(19)31041.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: